Gynecology Book

//fpnotebook.com/

Transdermal Estrogen

Aka: Transdermal Estrogen, Estraderm, Estrasorb, Transdermal Estradiol, Evanmist, Estrogel, Elestrin, Divigel, Vivelle Dot, Minivelle
  1. See Also
    1. Menopause
    2. Estrogen Replacement
    3. Continuous Estrogen Replacement
    4. Sequential Estrogen Replacement
    5. Vaginal Estrogen
  2. Indications
    1. Osteoporosis Prevention in postmenopausal women (Estraderm or Estrasorb)
      1. As of 2015, Estrogen is not recommended by ACOG or AAFP for chronic condition prevention
    2. Hot Flashes (Evanmist, Estrogel, Elestrin, Divigel)
  3. Advantages
    1. Studies suggest no increased Thromboembolism risk
      1. Scarabin (2003) Lancet 362:428-32 [PubMed]
  4. Efficacy: Osteoporosis Prevention (Estraderm or Estrasorb)
    1. Placebo
      1. Hip BMD: 2.04% loss
      2. Lumbar Spine BMD: 2.49% loss
    2. Dose: 0.025 mg Estradiol patch
      1. Hip BMD: 0.26% gain
      2. Lumbar Spine BMD: 2.37% gain
    3. Dose: 0.05 mg Estradiol patch
      1. Hip BMD: 2.85% gain
      2. Lumbar Spine BMD: 4.09% gain
    4. Dose: 0.06 mg Estradiol patch
      1. Hip BMD: 3.05% gain
      2. Lumbar Spine BMD: 3.28% gain
    5. Dose: 0.1 mg Estradiol patch
      1. Hip BMD: 2.03% gain
      2. Lumbar Spine BMD: 4.70% gain
    6. References
      1. Weiss (1999) Obstet Gynecol 94:330-6 [PubMed]
  5. Preparations: Transdermal Combination Progesterone and Estrogen
    1. Activella (17B-Estradiol-Norethindrone Acetate)
      1. Contains 1 mg Estradiol with 0.5 mg Norethindrone
    2. Climara Pro (17B-Estradiol-Levonorgestrel)
      1. Patch contains 0.045 mg Estradiol with 0.015 Levonorgestrel
      2. Patch applied weekly
    3. Combipatch (17B-Estradiol-Norethindrone Acetate)
      1. Patch contains 0.05 mg Estradiol with 0.014 or 0.25 mg Norethindrone
      2. Patch applied twice weekly
  6. Preparations: Agents used for Osteoporosis (Transdermal Estradiol)
    1. Preparations must be taken with Progesterone if Uterus intact (Endometrial Hyperplasia risk)
      1. See Continuous Estrogen Replacement
      2. See Sequential Estrogen Replacement
    2. Estrasorb (Transdermal Estradiol)
      1. Two foil packs equivalent to 0.05 mg Estradiol
      2. Rub one packet on right top of thigh, back of calf
      3. Repeat with second packet on left leg
      4. Do not apply with Sunscreen (increases absorption)
    3. Estraderm (Transdermal Estradiol Patch)
      1. Dosing: 0.05 mg Estradiol
      2. Change patch twice weekly using a different site
      3. Apply to non-irritated skin
        1. Lower Abdomen
        2. Buttock
        3. Do not apply to Breast
  7. Preparations: Agents used for Menopausal Hot Flashes (Transdermal Estradiol)
    1. Preparations must be taken with Progesterone if Uterus intact (Endometrial Hyperplasia risk)
      1. See Continuous Estrogen Replacement
      2. See Sequential Estrogen Replacement
    2. Evanmist
      1. Dosing: 1-3 sprays per day on inner Forearm to adjacent areas (not overlapping)
      2. Allow skin to dry for 30 minutes
    3. Estrogel (0.06% Estradiol)
      1. Pump delivers 0.75 mg of Estradiol (64 actuations per device)
      2. Apply gel from one wrist to the Shoulder, spreading thinly
    4. Elestrin (0.06% Estradiol)
      1. Pump delivers 0.52 mg of Estradiol (100 actuations per device)
      2. Apply to upper arm and Shoulder
      3. Allow to dry for 2 hours before immersing in water (e.g. swimming)
    5. Divigel (0.1% Estradiol)
      1. Foil packet delivers either 0.25 mg, 0.5 mg or 1.0 mg Estradiol per packet
      2. Apply packet contents to one upper thigh (5x7 inch area)
      3. Alternate to opposite side on subsequent application days
      4. Allow to dry for 1 hour before washing the area
  8. References
    1. Filer (1994) Am Fam Physician 49(7):1639-42 [PubMed]
    2. Hill (2016) Am Fam Physician 94(11): 884-9 [PubMed]
Medication Costs
elestrin (on 10/19/2016 at Medicaid.Gov Pharmacy Drug pricing)
ELESTRIN 0.06% GEL $3.42 per gram
divigel (on 2/3/2017 at Medicaid.Gov Pharmacy Drug pricing)
DIVIGEL 0.25 MG GEL PACKET $3.73 each
DIVIGEL 0.5 MG GEL PACKET $3.67 each
DIVIGEL 1 MG GEL PACKET $3.72 per gram
minivelle (on 2/22/2017 at Medicaid.Gov Pharmacy Drug pricing)
MINIVELLE 0.025 MG PATCH $17.77 each
MINIVELLE 0.0375 MG PATCH $17.97 each
MINIVELLE 0.05 MG PATCH $18.03 each
MINIVELLE 0.075 MG PATCH $18.03 each
MINIVELLE 0.1 MG PATCH $18.03 each
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information.

Estraderm (C0720290)

Concepts Pharmacologic Substance (T121) , Hormone (T125) , Steroid (T110)
English Estraderm, estraderm
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Estrasorb (C1320235)

Concepts Steroid (T110) , Pharmacologic Substance (T121) , Hormone (T125)
SnomedCT 406454003
English estrasorb, Estrasorb (product), Estrasorb
Spanish Estrasorb (producto), Estrasorb
Sources
Derived from the NIH UMLS (Unified Medical Language System)


transdermal estrogen (C1831768)

Definition (NCI) A transdermal formulation containing the synthetic form of estradiol, the most potent, endogenously produced estrogen. Upon topical administration, estradiol diffuses through the cell membrane and binds to and activates specific intracellular estrogen receptors located on estrogen-responsive tissues, including the reproductive tract, breast, pituitary, hypothalamus, liver, and bone. The activated ligand-receptor complex binds to estrogen response elements on DNA and promotes the transcription of genes involved in the functioning of the female reproductive system and secondary sex characteristics. In addition, estradiol inhibits the pituitary secretion of the gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH) through a negative feedback mechanism.
Definition (PDQ) A transdermal formulation containing the synthetic form of estradiol, the most potent, endogenously produced estrogen. Upon topical administration, estradiol diffuses through the cell membrane and binds to and activates specific intracellular estrogen receptors located on estrogen-responsive tissues, including the reproductive tract, breast, pituitary, hypothalamus, liver, and bone. The activated ligand-receptor complex binds to estrogen response elements on DNA and promotes the transcription of genes involved in the functioning of the female reproductive system and secondary sex characteristics. In addition, estradiol inhibits the pituitary secretion of the gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH) through a negative feedback mechanism. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=472200&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=472200&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C61440" NCI Thesaurus)
Concepts Pharmacologic Substance (T121) , Steroid (T110) , Hormone (T125)
English transdermal estrogen, Transdermal Estrogen, Estrodiol Gel
Sources
Derived from the NIH UMLS (Unified Medical Language System)


You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree